欧普康视：盐酸毛果芸香碱滴眼液获得药物临床试验批准

Core Viewpoint - The company, Opcon Vision (300595.SZ), has received approval from the National Medical Products Administration for clinical trials of its drug, "Pilocarpine Hydrochloride Eye Drops" [1] Group 1: Company Developments - The approval notification number for the clinical trial is 2025LP03261 [1] - The drug, Pilocarpine Hydrochloride, is an M-cholinergic receptor agonist that activates smooth muscle, specifically the iris sphincter and ciliary muscle [1] - The drug aims to treat presbyopia in adults by inducing pupil constriction to increase depth of focus and improve near and intermediate vision while maintaining light response [1] Group 2: Industry Context - The mechanism of action involves the contraction of the iris sphincter to enhance depth of focus and the contraction of the ciliary muscle to improve adaptability [1]